JP2011188872A5 - - Google Patents

Download PDF

Info

Publication number
JP2011188872A5
JP2011188872A5 JP2011148711A JP2011148711A JP2011188872A5 JP 2011188872 A5 JP2011188872 A5 JP 2011188872A5 JP 2011148711 A JP2011148711 A JP 2011148711A JP 2011148711 A JP2011148711 A JP 2011148711A JP 2011188872 A5 JP2011188872 A5 JP 2011188872A5
Authority
JP
Japan
Prior art keywords
antigen
cell
interleukin
dendritic cells
immature dendritic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011148711A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011188872A (ja
JP5777956B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011188872A publication Critical patent/JP2011188872A/ja
Publication of JP2011188872A5 publication Critical patent/JP2011188872A5/ja
Application granted granted Critical
Publication of JP5777956B2 publication Critical patent/JP5777956B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2011148711A 2001-09-06 2011-07-04 単球性樹状細胞およびt細胞にth−1応答をプライミングするための組成物および方法 Expired - Fee Related JP5777956B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31759201P 2001-09-06 2001-09-06
US60/317,592 2001-09-06

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2003526345A Division JP2005505270A (ja) 2001-09-06 2002-09-06 単球性樹状細胞およびt細胞にth−1応答をプライミングするための組成物および方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015040165A Division JP6114768B2 (ja) 2001-09-06 2015-03-02 単球性樹状細胞およびt細胞にth−1応答をプライミングするための組成物および方法

Publications (3)

Publication Number Publication Date
JP2011188872A JP2011188872A (ja) 2011-09-29
JP2011188872A5 true JP2011188872A5 (enExample) 2012-10-18
JP5777956B2 JP5777956B2 (ja) 2015-09-16

Family

ID=32654226

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2003526345A Pending JP2005505270A (ja) 2001-09-06 2002-09-06 単球性樹状細胞およびt細胞にth−1応答をプライミングするための組成物および方法
JP2011148711A Expired - Fee Related JP5777956B2 (ja) 2001-09-06 2011-07-04 単球性樹状細胞およびt細胞にth−1応答をプライミングするための組成物および方法
JP2015040165A Expired - Fee Related JP6114768B2 (ja) 2001-09-06 2015-03-02 単球性樹状細胞およびt細胞にth−1応答をプライミングするための組成物および方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2003526345A Pending JP2005505270A (ja) 2001-09-06 2002-09-06 単球性樹状細胞およびt細胞にth−1応答をプライミングするための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015040165A Expired - Fee Related JP6114768B2 (ja) 2001-09-06 2015-03-02 単球性樹状細胞およびt細胞にth−1応答をプライミングするための組成物および方法

Country Status (17)

Country Link
US (2) US20050059151A1 (enExample)
EP (3) EP1441591B1 (enExample)
JP (3) JP2005505270A (enExample)
KR (3) KR101803702B1 (enExample)
CN (2) CN102973928B (enExample)
AU (1) AU2008221592B2 (enExample)
BR (1) BRPI0212545B8 (enExample)
CA (1) CA2459713C (enExample)
DK (2) DK1441591T3 (enExample)
ES (2) ES2766299T3 (enExample)
IL (3) IL160720A0 (enExample)
MX (1) MXPA04002147A (enExample)
NO (2) NO338147B1 (enExample)
NZ (1) NZ531530A (enExample)
PL (1) PL372098A1 (enExample)
PT (2) PT1441591T (enExample)
WO (1) WO2003022215A2 (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT412145B (de) * 2002-09-13 2004-10-25 Forsch Krebskranke Kinder Verfahren zur herstellung eines zellulären immuntherapeutikums auf basis von il-12-freisetzenden dendritischen zellen
US20040057935A1 (en) * 2002-09-20 2004-03-25 Cedars-Sinai Medical Center Intratumoral delivery of dendritic cells
AU2003293411B2 (en) * 2002-12-06 2010-10-28 Northwest Biotherapeutics, Inc. Administration of dendritic cells partially matured in vitro for the treatment of tumors
ES2321939T3 (es) * 2003-02-27 2009-06-15 Northwest Biotherapeutics, Inc. Generacion de celulas dendriticas a partir de celulas precursoras dendriticas monociticas con gm-csf en ausencia de citoquinas adicionales.
EP1484064A1 (en) 2003-06-04 2004-12-08 Gesellschaft für Biotechnologische Forschung Therapeutical composition containing dentritic cells and use thereof
US20080199484A1 (en) * 2003-10-06 2008-08-21 Cedars-Sinai Medical Center Use Of Cox-2 Inhibitor to Prevent T-Cell Anergy Induced By Dendritic Cell Therapy
EP1676132B1 (en) * 2003-10-21 2014-01-22 Cedars-Sinai Medical Center Combination of chemotherapy and administration of glioma-antigen-pulsed dendritic cells in the treatment of glioma
AU2004286144A1 (en) * 2003-11-04 2005-05-12 Dnavec Research Inc. Method for producing gene transferred dendritic cells
CN101006171A (zh) 2004-06-24 2007-07-25 株式会社载体研究所 含有单链负链rna病毒的抗癌剂
KR20080109717A (ko) * 2005-12-08 2008-12-17 노쓰웨스트 바이오써라퓨틱스, 인크. 미성숙 단핵구성 수지상 세포의 활성화를 유도하기 위한조성물 및 방법
EP1840206A1 (en) * 2006-03-28 2007-10-03 Gsf-Forschungszentrum Für Umwelt Und Gesundheit, Gmbh Compositions for the preparation of mature dendritic cells
CA2700573C (en) 2006-09-26 2016-11-22 Cedars-Sinai Medical Center Cancer stem cell antigen vaccines and methods
US8097256B2 (en) 2006-09-28 2012-01-17 Cedars-Sinai Medical Center Cancer vaccines and vaccination methods
US9068020B2 (en) * 2008-09-02 2015-06-30 Cedars-Sinai Medical Center CD133 epitopes
WO2010129895A2 (en) 2009-05-07 2010-11-11 Immunocellular Therapeutics, Ltd. Cd133 epitopes
US20150064217A1 (en) * 2012-02-02 2015-03-05 California Stem Cell, Inc. Pluripotent germ layer origin antigen presenting cancer vaccine
JP6134785B2 (ja) * 2012-05-31 2017-05-24 ジェイダブリュ クレアジェン インコーポレイテッド 樹状細胞成熟化組成物、およびこれを用いて抗原特異的樹状細胞を製造する方法
AU2020203845C1 (en) * 2012-09-06 2022-08-11 Orbis Health Solutions, Llc Tumor lysate loaded particles
US20140065173A1 (en) * 2012-09-06 2014-03-06 Orbis Health Solutions Llc Tumor lysate loaded particles
EP2931324B1 (en) 2012-12-12 2018-09-19 Orbis Health Solutions LLC Compositions and methods for tissue regeneration
WO2014127296A1 (en) 2013-02-14 2014-08-21 Immunocellular Therapeutics, Ltd Cancer vaccines and vaccination methods
CN104936612B (zh) * 2013-09-05 2021-01-01 奥比思健康解决方案有限责任公司 装载了肿瘤裂解物的微粒
EP3932392A1 (en) 2014-03-05 2022-01-05 Orbis Health Solutions LLC Vaccine delivery systems using yeast cell wall particles
US9972054B1 (en) 2014-05-20 2018-05-15 State Farm Mutual Automobile Insurance Company Accident fault determination for autonomous vehicles
US11669090B2 (en) 2014-05-20 2023-06-06 State Farm Mutual Automobile Insurance Company Autonomous vehicle operation feature monitoring and evaluation of effectiveness
US10599155B1 (en) 2014-05-20 2020-03-24 State Farm Mutual Automobile Insurance Company Autonomous vehicle operation feature monitoring and evaluation of effectiveness
US10181161B1 (en) 2014-05-20 2019-01-15 State Farm Mutual Automobile Insurance Company Autonomous communication feature use
US10373259B1 (en) 2014-05-20 2019-08-06 State Farm Mutual Automobile Insurance Company Fully autonomous vehicle insurance pricing
US10387962B1 (en) 2014-07-21 2019-08-20 State Farm Mutual Automobile Insurance Company Methods of reconstructing an accident scene using telematics data
US10157423B1 (en) 2014-11-13 2018-12-18 State Farm Mutual Automobile Insurance Company Autonomous vehicle operating style and mode monitoring
WO2017002045A1 (en) 2015-06-30 2017-01-05 Stemlab, Sa A viable cell population, method for production and uses thereof
CN107849537A (zh) * 2015-06-30 2018-03-27 西北生物治疗药物公司 诱发改善的或增加的抗肿瘤免疫应答的经最佳活化的树突细胞
US9870649B1 (en) 2015-08-28 2018-01-16 State Farm Mutual Automobile Insurance Company Shared vehicle usage, monitoring and feedback
US11348193B1 (en) 2016-01-22 2022-05-31 State Farm Mutual Automobile Insurance Company Component damage and salvage assessment
US10134278B1 (en) 2016-01-22 2018-11-20 State Farm Mutual Automobile Insurance Company Autonomous vehicle application
US11441916B1 (en) 2016-01-22 2022-09-13 State Farm Mutual Automobile Insurance Company Autonomous vehicle trip routing
US10324463B1 (en) 2016-01-22 2019-06-18 State Farm Mutual Automobile Insurance Company Autonomous vehicle operation adjustment based upon route
US10395332B1 (en) 2016-01-22 2019-08-27 State Farm Mutual Automobile Insurance Company Coordinated autonomous vehicle automatic area scanning
US11242051B1 (en) 2016-01-22 2022-02-08 State Farm Mutual Automobile Insurance Company Autonomous vehicle action communications
US11719545B2 (en) 2016-01-22 2023-08-08 Hyundai Motor Company Autonomous vehicle component damage and salvage assessment
KR102038114B1 (ko) * 2016-02-26 2019-10-30 주식회사 엘지화학 광학 점착제용 (메타)아크릴레이트기 함유 벤조페논의 제조방법 및 광학 점착제 조성물
WO2018160666A1 (en) * 2017-02-28 2018-09-07 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Short-term activated dc1s and methods for their production and use
WO2019183924A1 (en) * 2018-03-30 2019-10-03 Syz Cell Therapy Co. Improved multiple antigen specific cell therapy methods
US20240122975A1 (en) * 2019-10-07 2024-04-18 Northwest Biotherapeutics, Inc. In vitro methods and compositions for enhancing the activation of dendritic cells and t cells, and for inducing a th-1 immune response

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162504A (en) 1988-06-03 1992-11-10 Cytogen Corporation Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients
US5366866A (en) * 1991-07-25 1994-11-22 Duke University Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies OXA and OXB
US5227471A (en) * 1992-01-30 1993-07-13 Eastern Virginia Medical School Of The Medical College Of Hampton Roads Monoclonal antibody PD41 that binds to a prostate mucin antigen that is expressed in human prostatic carcinoma
US5788963A (en) * 1995-07-31 1998-08-04 Pacific Northwest Cancer Foundation Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
SK40898A3 (en) * 1995-10-04 1999-04-13 Immunex Corp Use of flt3-ligand, vaccine adjuvants, expand media, a preparation and cells population and method
US7659119B2 (en) * 1996-02-12 2010-02-09 Argos Therapeutics, Inc. Method and compositions for obtaining mature dendritic cells
DE69840739D1 (de) * 1997-10-27 2009-05-28 Merix Bioscience Inc Methode und Zusammensetzung zur Herstellung von reifen dendritischen Zellen
JP2000143534A (ja) * 1998-11-13 2000-05-23 Asahi Chem Ind Co Ltd 樹状細胞ワクチン及びその製造方法
JP2000279181A (ja) * 1999-04-01 2000-10-10 Japan Science & Technology Corp ヒト樹状細胞の発現遺伝子群
EP1254953A4 (en) * 1999-12-28 2004-06-02 Toyoshima Kumao Maturity-triggering agent for immature dendritic cells
US6247378B1 (en) * 2000-01-06 2001-06-19 Deere & Company Operator control device for an infinitely variable transmission
ATE530193T1 (de) * 2000-05-12 2011-11-15 Northwest Biotherapeutics Inc Verfahren zur steigerung der klasse i präsentation von exogenen antigene durch humane dendritische zellen
ES2254527T3 (es) * 2001-01-15 2006-06-16 I.D.M. Immuno-Designed Molecules Metodo para la preparacion de suspensiones de particulas submicronicas de agentes farmaceuticos.
WO2003010292A2 (en) * 2001-07-25 2003-02-06 Northwest Biotherapeutics, Inc. Methods and apparatus for enrichment and culture of monocytic dendritic cell precursors

Similar Documents

Publication Publication Date Title
JP2011188872A5 (enExample)
JP2005505270A5 (enExample)
Rao et al. Tumor‐derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro
JP2014511704A5 (enExample)
IL273516B2 (en) Methods of isolating t cells having antigenic specificity for a p53 cancer-specific mutation
Yanagibashi et al. Bacteroides induce higher IgA production than Lactobacillus by increasing activation-induced cytidine deaminase expression in B cells in murine Peyer’s patches
JP2013533745A5 (enExample)
CN103533955A (zh) 用于激发t细胞的方法
JPWO2020243561A5 (enExample)
AR107278A1 (es) Procedimientos de producción de linfocitos t y linfocitos t producidos por ellos
JP2012518409A5 (enExample)
Hou et al. Host response to Sendai virus in mice lacking class II major histocompatibility complex glycoproteins
JP2011500592A5 (enExample)
JP2011525191A5 (enExample)
WO2022052984A1 (en) Universal sars-cov-2 vaccine and preparation method thereof
Bergot et al. New approaches to immunotherapy for HPV associated cancers
JP2010538649A5 (enExample)
JP2020534313A5 (enExample)
Shi et al. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro
MX2013013228A (es) Particulas similares a virus y proceso para prepararlas.
JP2011522835A5 (enExample)
JP2010538619A5 (enExample)
Shaulov et al. CD8 T cell expansion and memory differentiation are facilitated by simultaneous and sustained exposure to antigenic and inflammatory milieu
Gedvilaite et al. Virus-like particles derived from major capsid protein VP1 of different polyomaviruses differ in their ability to induce maturation in human dendritic cells
IL265942B1 (en) A nucleotide sequence expressing an exosome anchor protein for use as a component